GLMD icon

Galmed Pharmaceuticals
GLMD

Overview Fund Activity

38 hedge funds and large institutions have $103M invested in Galmed Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
-6
Holders Change %
-13.64%
% of All Funds
0.87%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
11
Increased
7
Reduced
7
Closed
17
Calls
–
Puts
$172K
Net Calls
-$172K
Net Calls Change
-$172K

Top Buyers

1
MIH
1
Meitav Investment House
Israel
$8.95M
2
NCM
2
Nantahala Capital Management
Connecticut
$11.4M
3
II
3
Ibex Investors
Colorado
$5.68M
4
RJA
4
Raymond James & Associates
Florida
$984K
5
VC
5
Vivo Capital
California
$11.6M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$1.56M
2
BBA
2
Baker Bros. Advisors
New York
$4.4M
3
SM
3
Sabby Management
Florida
$599K
4
Alyeska Investment Group
4
Alyeska Investment Group
Illinois
$0
5
First Manhattan
5
First Manhattan
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
EP
51
Eversept Partners
New York
– -$119K -56 Closed
AS
52
Altshuler Shaham
Israel
– -$14K -24 Closed
Barclays
53
Barclays
United Kingdom
– -$18K -8 Closed
AG
54
Advisor Group
Arizona
– -$14K -7 Closed
EDRH
55
Edmond de Rothschild Holding
Switzerland
– -$1K -1 Closed
MIM
56
Monashee Investment Management
Massachusetts
– -$379K – –
1 2
3